Search results (50 results)

Nov 30 2022 by SHRADDHA ASHOK CHANDORKAR, DNB DO

A 45-year-old man presented with diminution of vision in both eyes with metamorphopsia, which was painless and gradually progressive in nature. BCVA at presentation were 6/40 and 6/36 for the right and left eye respectively. Anterior segment examination of both eyes was unremarkable. IOP were within normal limits. Fundus examination showed bilateral numerous yellowish white round closely spaced lesions extending radially from the vascular arcades till the periphery associated with an elevated grayish macular choroidal neovascular membrane (CNV) with multiple drusen in the macular area and posterior pole. Impression was Familial Dominant Drusen (Doyne Honeycomb Drusen) associated with CNVM, both eyes. Color fundus photograph and autofluorescence showed Familial Dominant Drusen with CNVM. Subsequently , the patient underwent periodic intravitreal injections of Ranibizumab in both eyes under guarded visual prognosis, for which he tolerated well.

Photographer: NATIONAL INSTITUTE OF OPHTHALMOLOGY, PUNE

Imaging device: ZEISS CLARUS

Condition/keywords: choroidal neovascular membrane (CNVM), Doyne's Honeycomb, FAMILIAL DOMINANT DRUSEN, IMIM (Online Mendelian Inheritance in Man), intravitreal injection, Malattia Leventinese

Jan 22 2020 by Gregg T. Kokame, MD, MMM, FASRS

45-year-old female, with choroidal osteoma. silicone oil droplet in the periphery, after intravitreal injection.

Photographer: Jaclyn Pisano

Imaging device: Clarus 700

Condition/keywords: choroidal osteoma, intravitreal injection, silicone oil

Jul 24 2020 by Darin R. Goldman, MD

Widefield fundus photograph of a 56-year-old male patient immediately following intravitreal anti-VEGF injection. Two air bubbles are visible within the mid-vitreous cavity.

Photographer: Alberto Velez, Retina Group of Florida

Imaging device: Zeiss Clarus

Condition/keywords: anti-VEGF, intravitreal, intravitreal injection

Apr 12 2017 by John T. Thompson, MD

Intravitreal injection of anti-VEGF drug.

Imaging device: Cell phone with macro lens

Condition/keywords: intravitreal injection

Sep 21 2022 by Zach Seim

Ultra-widefield fundus photograph of an 81 year old female with a Methotrexate bubble following an Intravitreal Injection for Proliferative Vitreoretinopathy. Patient has been presenting to the office for two week interval Methotrexate injections in her left eye. The image was taken prior to her eighth injection which revealed a residual Methotrexate bubble in her inferior retinal image. This patient was seeing "lots" of floaters, as well as having visual acuity of cc20/400 cc20/200 PH.

Photographer: Zach Seim

Imaging device: OPTOS California

Condition/keywords: bubble, fundus photograph, fundus photography, intravitreal injection, left eye, methotrexate, nasal retina, Optos, proliferative vitreoretinopathy (PVR), pseudocolor, ultra-wide field imaging

Mar 12 2025 by Virginia Gebhart

65 year old female 4 weeks s/p intravitreal Ozurdex implant for diabetic macular edema. Significant improvement of edema and SRF

Photographer: Virginia Gebhart, Retina Consultants of Carolina

Imaging device: Optos California

Condition/keywords: diabetic macular edema, DME, intravitreal implant, intravitreal injection, ozurdex, Ozurdex implant

Nov 13 2019 by Olivia Rainey

Ultra-wide field fluorescein angiogram at 29 seconds of a 52-year-old male with proliferative diabetic retinopathy affecting his right eye. Patient is receiving Eylea intravitreal injections and has had panretinal photocoagulation in the past. Patient's vision tested 20/40 and with pinholes to 20/30.

Photographer: Olivia Rainey

Imaging device: Optos California

Condition/keywords: diabetes, diabetic macular edema, early phase, FA early phase, fluorescein angiogram (FA), intravitreal injection, ischemia, pan-retinal photocoagulation (PRP), proliferative diabetic retinopathy (PDR)

Jun 21 2024 by Tejaswita Verma

Follow up right eye fundus photograph of a 27 year old male with vision 6/12 , diagnosed with systemic tuberculosis(mediastinal lymphadenopathy on chest CT) on oral steroids, and started on ATT .We can see a parafoveal sub-ILM hemorrhage with vascular sheathing and hemorrhages in inferior and temporal quadrants . The patient was advised anti-VEGF intravitreal injection, later sectoral laser after resolution of inflammation

Photographer: DR. TEJASWITA VERMA

Imaging device: MIRANTE

Condition/keywords: obliterative peripheral vasculitis, ocular tuberculosis

Feb 28 2013 by Theodore Leng, MD, MS, FASRS

OCT scan 4 weeks after a single intravitreal injection of aflibercept.

Imaging device: Zeiss Cirrus HD-OCT

Condition/keywords: aflibercept, central retinal vein occlusion (CRVO), cystoid macular edema (CME), EYLEA

Jan 26 2013 by Ratimir Lazic, MD, PhD

FAG image(arterial phase) of a 67-year-old female after 3 consecutive ranibizumab intravitreal injections due to CME caused by CRVO.

Photographer: Marko Lukic, MD

Imaging device: Zeis Visucam Lite 2

Condition/keywords: central retinal vein occlusion (CRVO)

Feb 27 2025 by Kimberly Wakester

Optomap RGB image of a 34-year-old woman with central retinal vein occlusion with macular edema in the left eye. Patient has had a fairly acute onset central retinal vein occlusion in her left eye with dense superior IRH and macular edema. Modest ischemic changes are seen on exam and fundus photos. Patient was educated on the etiology of CRVOs and the relationship to systemic risk factors. Recommended hypercoagulable work-up with her PCP and bloodwork was ordered. Treatment with intravitreal injections was recommended to reduce the macular edema. Patient is to continue monthly follow ups with repeat OCT.

Photographer: Kimberly Wakester, COA

Imaging device: Optos California

Condition/keywords: CRVO with macular edema

Jan 29 2025 by Kimberly Wakester

Fundus photograph of a 62-year-old man with central retinal vein occlusion with macular edema and a new PVD with an operculated retinal tear in the left eye. Laser to retinal tear was completed. Patient will return in 2-3 weeks for follow up exam with possible intravitreal injection for the CRVO with edema and to follow up on the operculated retinal tear s/p retinal tear laser.

Photographer: Kimberly Wakester, COA

Imaging device: Optos California

Condition/keywords: central retinal vein occlusion (CRVO), operculated tear, PVD

Jan 22 2020 by Gregg T. Kokame, MD, MMM, FASRS

45-year-old female, with choroidal osteoma. Silicone oil droplet in the periphery, after intravitreal injection.

Photographer: Jaclyn Pisano, Retina Consultants of Hawaii

Imaging device: Clarus 700

Condition/keywords: choroidal osteoma, silicone oil

Apr 6 2014 by Ratimir Lazic, MD, PhD

A color fundus image of a 7-year-old boy. Pigmented chorioretinal scar sorrounded by subretinal hemorrhage can be seen. VA is 0,2 by Snellen lines. The image presents the baseline clinical picture. The antiVEGF intravitreal injection, under general anesthesia, was administered.

Photographer: Marko Vlasic, University Eye Clinic Svjetlost

Imaging device: Zeis Visucam Lite 2

Condition/keywords: choroidal neovascularization (CNV), subretinal hemorrhage, toxoplasmosis

Aug 5 2020 by Dhaivat Shah

A 54-year-old healthy male presented to us with a decreased vision in right eye since past 8 years. The patient gave a history of bleed in right eye before 8 years for which some intravitreal injection was given; post which there no major visual improvement. No details or documentation was available regarding the same. His BCVA in the right eye was 5/60. Fundus examination revealed a sharply demarcated hypopigmented patch over the macula with mild posterior excavation suggestive of macular scar. OCT image shows foveal thinning with loss of Retinal pigment epithelium and outer retinal layers (RORA). There are 2 types of RORAs, complete and incomplete. Complete RORA and incomplete RORA are entities defined by various imaging modalities describing atrophy of the retinal pigment epithelial and the outer retinal layers. OCT imaging defines incomplete RORA (iRORA) as a region of signal hyper transmission into the choroid and a corresponding zone of attenuation ordisruption of the RPE (<250um) and evidence of overlying photoreceptor degeneration (<250um). There should not be any RPE tear associated with it. OCT imaging describes complete RORA (cRORA) based on 4 inclusion criteria. These include, area of hypertransmission of more than 250um, zone of attenuation or disruption of the RPE of more than 250um in diameter, evidence of overlying photoreceptor degeneration and absence of scrolled RPE or other signs of an RPE tear. Other modalities used to define these include fundus autoflourescence(FAF), near infrared reflectance(NIR) and color fundus photograph(CFP). On CFP, it shows a sharply demarcated hypopigmented of >250um size with better visibility of choroidal vessels. FAF shows a hypo autoflourescent patch with sharply demarcated borders of size >250um, the colour of which is similar to that of the optic nerve head or retinal blood vessels excluding any pigmentation or artefact. On NIR, it shows a hyperreflective area with sharply demarcated borders of >250um size excluding any artefact. RORA can be seen in conditions like geographical atrophy in ARMD, central areolar choroidal dystrophy, atrophy secondary to anti-VEGF treatment. References: 1. Sadda SR, Guymer R, Holz FG, et al. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3 [published correction appears in Ophthalmology. 2019 Jan;126(1):177]. Ophthalmology. 2018;125(4):537-548. 2. Guymer RH, Rosenfeld PJ, Curcio CA, et al. Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. Ophthalmology. 2020;127(3):394-409. 3. Eng VA, Rayess N, Nguyen HV, Leng T. Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration. PLoS One. 2020;15(5):e0232353.

Photographer: Miss Anjum Zafar Khan

Imaging device: Choithram Netralaya

Condition/keywords: macular scar, outer retina, retinal pigment epithelium

Nov 11 2019 by Sophia El Hamichi, MD

A 51-year-old female that presented with a macular choroidal hemagioma complicated by focal exudative retinal detachment OD. The patient was treated with vitrectomy and laser therapy of the choroidal hemagioma along with bevacizumab intravitreal injection during and after the surgery. The patient evolved well with resolution of the subretinal fluid OD. VA 20/200

Photographer: Sophia El Hamichi,MD, Murray Ocular Oncology and Retina, Miami

Condition/keywords: laser photocoagulation, subretinal fluid

Feb 2 2015 by Matt Poe, COA

The patient presented with total vision loss for >2months. Patient had history of exudative ARMD with intravitreal injections. No surgical intervention was done due to the long standing detachment and patient health.

Photographer: Matt Poe, COA. Northwest Arkansas Retina Associates, Springdale, AR.

Condition/keywords: retinal defect

Jan 28 2023 by Kingston Rodolfo Ureña-Wong, MD, Opht, MSc

Anterior segment photography of a 54-year-old woman with post phacoemulsification endophthalmitis. She did not improve after first intravitreal antibiotics injection and develop an inflammatory pupillary membrane. After two vitrectomies, and a complete three intravitreal injections scheme, we decided to remove the intraocular lens and capsules.

Photographer: Marco Antonio Rubio-Atonal,UNAM, Asociación para evitar la ceguera en México

Imaging device: Zeiss Clarus 700

Condition/keywords: endophthalmitis, pupillary membranes

Apr 12 2018 by Aaron P. Appiah, MD

68-years-old, African American female with history of diabetes mellitus and ischemic BRVO OD, S/P Eylea intravitreal injections for CSME -resolved.

Imaging device: Optos California

Condition/keywords: branch retinal vein occlusion (BRVO)

Apr 12 2018 by Aaron P. Appiah, MD

68-years-old, African American female with history of diabetes mellitus and ischemic BRVO OD, S/P Eylea intravitreal injections for CSME -resolved.

Imaging device: Optos California

Condition/keywords: branch retinal vein occlusion (BRVO)

Mar 22 2020 by Anfisa Ayalon, MD

Intraoperative images were taken during the management of submacular hemorrhage in age-related macular degeneration. The goal of the surgery was the physical displacement of SMH out of the fovea using expansile gas. The image from the left was done during ILM peeling. Note the massive collection of subretinal blood. The image from the right was done after submacular injection of t-PA, bevacizumab and filtered air. Intravitreal injection of 20% SF6 completed the surgery. The visual acuity improved after the surgery from HM to 1/60.

Photographer: Anfisa Ayalon, MD., Meir Medical Center, Kfar Saba, Israel.

Condition/keywords: spontaneous submacular hemorrhage, submacular hemorrhage, vitreomacular surgery, wet age-related macular degeneration (wet AMD)

Mar 22 2020 by Anfisa Ayalon, MD

Submacular hemorrhage in age-related macular degeneration. Image A: SD-OCT before the surgery. Note widespread submacular hemorrhage with subretinal fluid and RPE detachment. Image B: SD-OCT after the surgery (PPV+ERM and ILM peeling+Submacular injection of t-PA, bevacizumab and filtered air+ Intravitreal injection of 20% SF6 ). Note remaining RPE detachment with no OCT signs of submacular hemorrhage. The visual acuity improved after the surgery from HM to 1/60.

Photographer: Anfisa Ayalon, MD., Meir Medical Center, Kfar Saba, Israel.

Condition/keywords: age-related macular degeneration (AMD), optical coherence tomography (OCT), submacular hemorrhage

Jan 6 2020 by Sophia El Hamichi, MD

A 41-week-old girl, with a gestational age of 23 weeks and 4 days presenting with stage 4 A of ROP OU. She was treated with laser and intravitreal injections of bevacizumab.

Photographer: Abby Orcutt-Hayes, Murray Ocular Oncology and Retina

Condition/keywords: intravitreal bevacizumab, laser photocoagulation, montage, retinopathy of prematurity stage 4a

Mar 25 2013 by Ratimir Lazic, MD, PhD

Color fundus photography of a 33-year-old female. In macular area subretinal hemorrhage can be seen. Area of atrophy temporal from PNO. Myopic changes of posterior pole and mid periphery can be noticed. The patient has been treated with 2 consecutive ranibizumab intravitreal injections. BCVA at baseline was 0,05 (Snellen lines) and 0,3 (Snellen lines) 2 months after.

Photographer: Marko Lukic, MD

Imaging device: Zeis Visucam Lite 2

Condition/keywords: high myopia, myopic choroidal neovascularization (CNV), ranibizumab

Aug 23 2012 by Daniel A. Adelberg, MD, FASRS

Anterior Segment photograph of a 50 year old with Uveitis and Cystoid Macular Edema status post Intravitreal injection of an Ozurdex dexamethasone implant

Photographer: Robert Ramsey, Southwestern Eye Center, Mesa Arizona

Condition/keywords: Ozurdex implant